{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:28:18Z","timestamp":1791185298002,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T00:00:00Z","timestamp":1193270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1245\/s10434-007-9648-5","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T13:30:07Z","timestamp":1193232607000},"page":"535-541","source":"Crossref","is-referenced-by-count":71,"title":["Safety and Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with High-Dose Oxaliplatin in Patients with Peritoneal Carcinomatosis"],"prefix":"10.1245","volume":"15","author":[{"given":"Wim P.","family":"Ceelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Houtmeyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Breusegem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"De Somer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Pattyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,25]]},"reference":[{"key":"9648_CR1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354:34\u201343","journal-title":"N Engl J Med"},{"key":"9648_CR2","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00313.2004","volume":"288","author":"MF Flessner","year":"2005","unstructured":"Flessner MF. The transport barrier in intraperitoneal therapy. Am J Physiol Renal Physiol 2005; 288:F433\u2013F42","journal-title":"Am J Physiol Renal Physiol"},{"key":"9648_CR3","first-page":"878","volume":"8","author":"IF Tannock","year":"2002","unstructured":"Tannock IF, Lee CM, Tunggal JK, et al. Limited penetration of anticancer drugs through tumor tissue: A potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 2002; 8:878\u201384","journal-title":"Clin Cancer Res"},{"key":"9648_CR4","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21:3737\u201343","journal-title":"J Clin Oncol"},{"key":"9648_CR5","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1200\/JCO.2006.07.1142","volume":"24","author":"TD Yan","year":"2006","unstructured":"Yan TD, Black D, Savady R, et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006; 24:4011\u20139","journal-title":"J Clin Oncol"},{"key":"9648_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00003088-200443020-00005","volume":"43","author":"S Ruth van","year":"2004","unstructured":"van Ruth S, Mathot RAA, Sparidans RW, et al. Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy. Clin Pharmacokin 2004; 43:131\u201343","journal-title":"Clin Pharmacokin"},{"key":"9648_CR7","first-page":"1643","volume":"23","author":"S Zeamari","year":"2003","unstructured":"Zeamari S, Floot B, Van der Vange N, et al. Pharmacokinetics and pharmacodynamics of cisplatin after Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC). Anticancer Res 2003; 23:1643\u20138","journal-title":"Anticancer Res"},{"key":"9648_CR8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/bjc.1994.45","volume":"69","author":"G Los","year":"1994","unstructured":"Los G, Vanvugt MJH, Pinedo HM. Response of peritoneal solid tumors after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 1994; 69:235\u201341","journal-title":"Br J Cancer"},{"key":"9648_CR9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/annonc\/mdl029","volume":"17","author":"I Chau","year":"2006","unstructured":"Chau I, Cunningham D. Adjuvant therapy in colon cancer \u2013 what, when and how? Ann Oncol 2006; 17:1347\u201359","journal-title":"Ann Oncol"},{"key":"9648_CR10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2006.08.011","volume":"104","author":"JC Elkas","year":"2007","unstructured":"Elkas JC, Winter WE, Chernofsky MR, et al. A phase I trial of oxaliplatin and topotecan in recurrent ovarian carcinoma. Gynecol Oncol 2007; 104:422\u20137","journal-title":"Gynecol Oncol"},{"key":"9648_CR11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.2004.07.042","volume":"22","author":"SE Al-Batran","year":"2004","unstructured":"Al-Batran SE, Atmaca A, Hegewisch-Becker S, et al. Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer. J Clin Oncol 2004; 22:658\u201363","journal-title":"J Clin Oncol"},{"key":"9648_CR12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.lungcan.2004.08.005","volume":"47","author":"DA Fennell","year":"2005","unstructured":"Fennell DA, Steele JPC, Shamash J, et al. Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma. Lung Cancer 2005; 47:277\u201381","journal-title":"Lung Cancer"},{"key":"9648_CR13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01212608","volume":"123","author":"RC Rietbroek","year":"1997","unstructured":"Rietbroek RC, vandeVaart PJM, Haveman J, et al. Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells. J Cancer Res Clin Oncol 1997; 123:6\u201312","journal-title":"J Cancer Res Clin Oncol"},{"key":"9648_CR14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1096-9098(200102)76:2<106::AID-JSO1020>3.0.CO;2-E","volume":"76","author":"SR Pestieau","year":"2001","unstructured":"Pestieau SR, Belliveau JF, Griffin H, et al. Pharmacokinetics of intraperitoneal oxaliplatin: Experimental studies. J Surg Oncol 2001; 76:106\u201314","journal-title":"J Surg Oncol"},{"key":"9648_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdf019","volume":"13","author":"D Elias","year":"2002","unstructured":"Elias D, Bonnay A, Puizillou JM, et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: Pharmacokinetics and tissue distribution. Ann Oncol 2002; 13:267\u201372","journal-title":"Ann Oncol"},{"key":"9648_CR16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1023\/B:PHAM.0000026444.67883.83","volume":"21","author":"E Jerremalm","year":"2004","unstructured":"Jerremalm E, Hedeland M, Wallin I, et al. Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex. Pharm Res 2004; 21:891\u20134","journal-title":"Pharm Res"},{"key":"9648_CR17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","volume":"15","author":"L Rubbia-Brandt","year":"2004","unstructured":"Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15:460\u20136","journal-title":"Ann Oncol"},{"key":"9648_CR18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0399-8320(06)73542-4","volume":"30","author":"R Arotcarena","year":"2006","unstructured":"Arotcarena R, Cales V, Berthelemy P, et al. Severe sinusoidal lesions: A serious and overlooked complication of oxaliplatin-containing chemotherapy? Gastroenterol Clin Biol 2006; 30:1313\u20136","journal-title":"Gastroenterol Clin Biol"},{"key":"9648_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy Procedures. Ann Surg 1995; 221:29\u201342","journal-title":"Ann Surg"},{"key":"9648_CR20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10434-999-0790-0","volume":"6","author":"AD Stephens","year":"1999","unstructured":"Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 1999; 6:790\u20136","journal-title":"Ann Surg Oncol"},{"key":"9648_CR21","doi-asserted-by":"crossref","first-page":"543S","DOI":"10.1200\/jco.2004.22.14_suppl.6098","volume":"22","author":"AD Colevas","year":"2004","unstructured":"Colevas AD, Setser A. The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials. J Clin Oncol 2004; 22:543S","journal-title":"J Clin Oncol"},{"key":"9648_CR22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1525-1438.2007.00763.x","volume":"17","author":"P Harnett","year":"2007","unstructured":"Harnett P, Buck M, Beale P, et al. Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: An Australian and New Zealand Gynaecological Oncology Group study. Int J Gynecol Cancer 2007; 17:359\u201366","journal-title":"Int J Gynecol Cancer"},{"key":"9648_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-0-387-48993-3_12","volume-title":"Peritoneal carcinomatosis: A multidisciplinary approach","author":"WP Ceelen","year":"2007","unstructured":"Ceelen WP, Pahlman L, Mahteme H. Pharmacodynamic aspects of Intraperitoneal Cytotoxic therapy. In: Ceelen WP (ed) Peritoneal carcinomatosis: A multidisciplinary approach. New York, Springer; 2007. pp 195\u2013214"},{"key":"9648_CR24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000066229","volume":"63","author":"D Elias","year":"2002","unstructured":"Elias D, El Otmany A, Bonnay M, et al. Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis. Oncology 2002; 63:346\u201352","journal-title":"Oncology"},{"key":"9648_CR25","unstructured":"Reed E. Cisplatin, Carboplatin, and Oxaliplatin. In: Chabner BA, Longo DL (eds) Cancer Chemotherapy & Biotherapy: Principles & Practices, 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2006"},{"key":"9648_CR26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","volume":"94","author":"D Zorzi","year":"2007","unstructured":"Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94:274\u201386","journal-title":"Br J Surg"},{"key":"9648_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200038010-00001","volume":"38","author":"F Levi","year":"2000","unstructured":"Levi F, Metzger G, Massari C, Milano G. Oxaliplatin: pharmacokinetics and chronopharmacological aspects. Clin Pharmacokinet 2000; 38:1\u201321","journal-title":"Clin Pharmacokinet"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9648-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-007-9648-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9648-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:53:07Z","timestamp":1559609587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-007-9648-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,25]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["9648"],"URL":"https:\/\/doi.org\/10.1245\/s10434-007-9648-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,25]]}}}